1-12 of 12
Masahide Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial

Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Norio Shimizu, Ryuji Koike, Ayako Arai
Journal: Blood
Blood (2022) 140 (Supplement 1): 6571–6572.
https://doi.org/10.1182/blood-2022-168565
Published: 2022
Journal Articles

The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

Ayako Arai, Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta
Journal: Blood
Blood (2021) 138 (Supplement 1): 3965.
https://doi.org/10.1182/blood-2021-147046
Published: 2021
Journal Articles

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, Satoru Takada, Tatsuki Tomikawa, Hiroshi Handa, Yuna Katsuoka, Daiki Hirano, Nobuo Sezaki, Masahiko Sumi, Shin Fujisawa, Yasuhiro Taniguchi, Takuro Yoshimura, Eiichi Ohtsuka, Ken Takase, Youko Suehiro, Shuichi Ota, Tomohiro Kajiguchi, Tomoya Maeda, Masahide Yamamoto, Shigeki Ohtake, Akira Katsumi, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Journal: Blood
Blood (2021) 138 (Supplement 1): 2925.
https://doi.org/10.1182/blood-2021-147587
Published: 2021
Journal Articles

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

Chikashi Yoshida, Hiroki Yamaguchi, Noriko Doki, Kazunori Murai, Masaki Iino, Yoshihiro Hatta, Makoto Onizuka, Norio Yokose, Katsumichi Fujimaki, Masao Hagihara, Gaku Oshikawa, Kayoko Murayama, Takashi Kumagai, Shinya Kimura, Hideharu Muto, Kensuke Usuki, Kenji Yokoyama, Koh Yamamoto, Nobuyuki Aotsuka, Kenichi Ishizawa, Naoki Takezako, Takuto Miyagishima, Tadao Ishida, Atsushi Shinagawa, Kentaro Wakasa, Tsuyoshi Nakamaki, Naoto Tomita, Katsutoshi Ozaki, Takayoshi Itoh, Shugo Kowata, Kenji Tajika, Takayuki Fujio, Masahiro Onozawa, Masahide Yamamoto, Takeshi Kondo, Yuho Najima, Noriyoshi Iriyama, Ikuyo Tsutsumi, Koji Oba, Hiroshi Kojima, Hisashi Sakamaki, Koiti Inokuchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1477.
https://doi.org/10.1182/blood-2021-145483
Published: 2021
Journal Articles

Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

Daisuke Kudo, MD, Takuya Komeno, MD MPH, PhD, Chikashi Yoshida, MD PhD, Ikuyo Ota Tsutsumi, MD, Kazuteru Ohashi, MD PhD, Kazuhiko Kakihana, MD PhD, Takeshi Kobayashi, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Aiko Igarashi, MD, Mitsuo Hori, MD PhD, Yasushi Okoshi, MD PhD, Takayuki Fujio, MD, Atsushi Shinagawa, MD PhD, Masahide Yamamoto, MD PhD, Hina Takano, MD PhD, Takashi Kumagai, MD PhD, Koh Yamamoto, MD PhD, Shigeo Toyota, MD PhD, Yuichi Nakamura, MD PhD, Hiroshi Kojima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2160.
https://doi.org/10.1182/blood-2018-99-113788
Published: 2018
Journal Articles

A Novel Cell Line, Tnet-2, Derived from "Triple-Negative" Essential Thrombocythemia

Satoru Aoyama, MD MMSc, Toshikage Nagao, MD PhD, Shunichiro Yasuda, MD, Daisuke Watanabe, MD, Hiroki Akiyama, MD, Shinya Ishida, MD, Ayako Nogami, MD, PhD, Yoshihiro Umezawa, MD, Ken Watanabe, MD PhD, Masahide Yamamoto, MD PhD, Osamu Miura, MD, PhD, Norihiko Kawamata, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5493.
https://doi.org/10.1182/blood-2018-99-114457
Published: 2018
Journal Articles

Systemic Following Intravitreal MTX Administration Prevents CNS Infiltration of Primary Intraocular Lymphoma

Hiroki Akiyama, MD, Hiroshi Takase, MDPhD, Fumito Kubo, MD, Tohru Miki, MD PhD, Masahide Yamamoto, MD PhD, Makoto Tomita, PhD, Manabu Mochizuki, MDPhD, Osamu Miura, MD PhD, Ayako Arai, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3053.
https://doi.org/10.1182/blood.V124.21.3053.3053
Published: 2014
Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Mitsune Tanimoto, MD PhD, Koichi Miyamura, Toshihiro Miyamoto, MD PhD, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, MD, Kazuma Ohyashiki, Tatsuya Kawaguchi, MD PhD, Itaru Matsumura, Tomoko Hata, MD PhD, Hisashi Tsurumi, MD PhD, Shigeki Saito, MD PhD, Masayuki Hino, MD PhD, Seiji Tadokoro, Kuniaki Meguro, MD PhD, Hideo Hyodo, MD, Masahide Yamamoto, MD PhD, Kohmei Kubo, MD PhD, Junichi Tsukada, MD, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood
Blood (2014) 124 (21): 1815.
https://doi.org/10.1182/blood.V124.21.1815.1815
Published: 2014
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013
Journal Articles

Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia,

Naoto Takahashi, MD, PhD, Taiichi Kyo, MD, Yasuhiro Maeda, MD, PhD, Takashi Sugihara, MD, PhD, Kensuke Usuki, MD, Tatsuya Kawaguchi, MD, PhD, Noriko Usui, MD, Shinichiro Okamoto, MD, PhD, Yokiko Ohe, MD, Shigeki Ohtake, MD, PhD, Kunio Kitamura, Masahide Yamamoto, MD, Hirofumi Teshima, MD, Toshiko Motoji, MD, PhD, Toshiharu Tamaki, MD, Kenichi Sawada, MD, PhD, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3759.
https://doi.org/10.1182/blood.V118.21.3759.3759
Published: 2011
Journal Articles

Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era

Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Saburo Tsunoda, Yasufumi Masaki, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Oshima, Yoshihiro Hatta, Yoshiyuki Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Yoshiaki Ishigatsubo, Kengo Takeuchi
Journal: Blood
Blood (2010) 116 (21): 3948.
https://doi.org/10.1182/blood.V116.21.3948.3948
Published: 2010
Journal Articles

Cystatin C Level as a Marker of Renal Function in Hematopoietic Stem Cell Transplantation

Hideharu Muto, Kazuteru Ohashi, Minoru Ando, Ryo Hanajiri, Taku Kikuchi, Wataru Munakata, Chihiro Sakurai, Masahide Yamamoto, Takeshi Kobayashi, Takuya Yamashita, Hideki Akiyama, Hisashi Sakamaki
Journal: Blood
Blood (2008) 112 (11): 4306.
https://doi.org/10.1182/blood.V112.11.4306.4306
Published: 2008